Category archives for: Online Pharmacies

The European Medicines Agency Accepts Marketing Authorisation Application for Intrarosa for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of vulvar and vaginal atrophy in postmenopausal women. IntrarosaTM will be available as a […]

Unlocking a Growing Potential in a Crowded Pharma Market

marcus evans Pharma 2018: Sales & Marketing Excellence Forum is gathering the major practitioners from the globe and China, bringing innovation and collaboration to the industry for you to achieve the best commercial outcomes. [PR.com]

WiCON|Pharma China: Chinese Drug Market Growth Projected to Slow But Stabilize in the Next Five Years

The Chinese drug market growth is expected to fall further to 7.6% valued at CNY 1,611.8 billion (at retail price level) in 2017 as a result of tender price pressure, eliminated hospital drug sales margin and stringent government cost containment measures, according to WiCON|Pharma China (www.pharmachinaonline.com) quoting Jianning Lin, President of the Southern Medicine Economic […]

A Practical Discussion About AI and Machine Learning in Healthcare Digital Marketing

Arteric’s President Prepares Healthcare Marketers to Transform Digital Disruption Into Competitive Advantage. [PR.com]

M&S tries to reinvent itself – but things are always happening to it | Nils Pratley

Like Paddington Bear, Marks & Spencer’s good intentions are often frustrated by events – in its case, tough trading conditions Paddington Bear, the star of Marks & Spencer’s Christmas ad, always kept a marmalade sandwich in his hat in case of emergency. M&S itself just reaches for another restructuring. The latest rejig is not the […]

Intellectual Property and Regulatory Law: Recent Developments | Parallel Trade 2018

SMi’s 12th annual Parallel Trade conference, will return to Central London, 6th – 7th February 2018 to explore the relationship between parallel trader and the pharmaceutical industry. [PR.com]

Taxpayers pay twice for crucial drugs like Avastin | Letters

Big pharma companies are charging over the odds for medicines developed with public funding, write Heidi Chow and Tabitha Ha It is shocking, but not surprising, that big drugs companies are threatening to sue the NHS for using cheaper versions of drugs that could save people from going blind (Drug firms trying to stop cheap […]

The need to incentivise antibiotic research | Letters

Thoughtful governmental action can make development of new drugs for small patient populations viable, says Prof David Roblin, while Dr Georgina Crayford responds to an article on efforts to cut the use of antibiotics in farming David Cox reports on the “war on bugs” and development of “superantibiotics” (23 October). A blunderbuss is effective against […]

New to 2018: The Role of Artificial Intelligence in Drug Discovery

SMi Reports: SMi’s 2nd annual Drug Discovery conference, taking place in London on 21st and 22nd March 2018, will discuss the role of artificial intelligence in drug discovery. [PR.com]

Veteran Pharmaceutical Commercial Strategy Expert Hensley Evans Joins the HealthPrize Technologies Board of Directors

The ZS Associates principal will bring her expansive patient engagement and multi-channel marketing experience to HealthPrize’s board. [PR.com]

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us